Greater Intermountain Node

大山间节点

基本信息

  • 批准号:
    10371229
  • 负责人:
  • 金额:
    $ 147.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT The scope of the current opioid crisis necessitates a broad-based health system response to addiction that extends beyond the specialty addiction care system. There is a critical need to expand research infrastructure to develop, test, and implement new clinical interventions and evidence-based opioid use disorder (OUD) treatment into diverse clinical settings. We propose the University of Utah’s (UofU) Greater Intermountain Node (GIN) to expand the existing NIH NIDA Clinical Trial Network’s (CTN) infrastructure by developing and testing innovative OUD interventions, expanding the settings for CTN research, and bringing new research acumen to the CTN. The GIN brings expertise in three spheres of OUD research: 1) non-addiction health care settings, 2) large health systems of care, and 3) implementation science. GIN’s sphere of non-addiction specialty care settings research will enable the CTN to continue and further establish these settings for OUD research by leveraging environments where GIN faculty are conducting ongoing research, for example, in primary care, obstetrical, and community pharmacies. GIN’s sphere of health systems of care research will enable the CTN access to Utah’s comprehensive, linked health/social service system databases and the Veterans Health Administration integrated data system in addition to bringing extensive experience in data science and informatics. GIN’s sphere of implementation science will allow CTN to promote and support implementation research proposals, expertise, and environments with a focus on studying/improving implementation of medication treatment for OUD, OUD identification and treatment in rural clinical settings, and improving provider knowledge, attitudes, and clinical behaviors toward patients with OUD. Advancing the work of these targeted spheres will enable the GIN to successfully achieve the following Specific Aims (SA): SA1: Enhance CTN’s ability to conduct research in primary care and non-addiction care settings (e.g. primary care, inpatient, pharmacy); SA2: Enhance CTN’s ability to conduct research within integrated systems of care with “big data” resources (Utah population-level databases, VA); and SA3: Enhance CTN’s ability to conduct implementation science research to rapidly and effectively integrate and disseminate evidence-based addiction care into diverse non-addiction and health system targets. The GIN’s interdisciplinary leadership team has a proven track record in addiction investigative scholarship. We will leverage a robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, and community stakeholders.
项目摘要 目前阿片类药物危机的范围需要一个基础广泛的卫生系统对成瘾作出反应, 超越了专业戒毒治疗系统迫切需要扩大研究基础设施 开发,测试和实施新的临床干预措施和基于证据的阿片类药物使用障碍(OUD) 在不同的临床环境中进行治疗。我们建议犹他州大学(UofU)的大山间节点 (GIN)通过开发和测试现有的NIH NIDA临床试验网络(CTN)基础设施, 创新的OUD干预措施,扩大CTN研究的设置,并带来新的研究敏锐度, CTN。GIN带来了OUD研究三个领域的专业知识:1)非成瘾医疗保健环境,2) 大型医疗保健系统,以及3)实施科学。GIN的非成瘾专业护理领域 环境研究将使CTN能够继续并进一步为OUD研究建立这些环境, 利用GIN教师正在进行研究的环境,例如,在初级保健中, 产科和社区药房。GIN的护理研究卫生系统领域将使CTN 访问犹他州全面的、链接的健康/社会服务系统数据库和退伍军人健康 管理集成数据系统,除了带来丰富的数据科学经验, 信息学. GIN的实施科学领域将使CTN能够促进和支持实施 研究建议,专业知识和环境,重点是研究/改善实施 OUD的药物治疗,农村临床环境中OUD的识别和治疗,以及改善 提供者对OUD患者的知识、态度和临床行为。推动这些机构的工作 有针对性的球体将使全球导航网能够成功地实现以下特定目标(SA): CTN在初级保健和非成瘾护理环境(如初级保健,住院, SA 2:增强CTN在综合护理系统中利用“大数据”进行研究的能力 资源(犹他州人口级数据库,弗吉尼亚州);和SA 3:提高CTN的能力,进行实施 科学研究,快速有效地将循证成瘾护理整合和传播到 不同的非成瘾和卫生系统目标。GIN的跨学科领导团队拥有经过验证的 在成瘾调查奖学金方面的成绩我们将利用强有力的机构承诺, 基础设施,专注于成瘾相关研究的机构中心,以及具有强大 与临床医生、教育工作者和社区利益相关者的区域和国家联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gerald T. Cochran其他文献

Prescribing, Prescription Monitoring, and Health Policy
处方、处方监测和健康政策
  • DOI:
    10.1007/978-3-030-16257-3_11
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Gordon;Gerald T. Cochran;M. Smid;A. Manhapra;S. Kertesz
  • 通讯作者:
    S. Kertesz
Caring for Opioid Dependent Pregnant Women: Prenatal and Postpartum Care Considerations
照顾阿片类药物依赖孕妇:产前和产后护理注意事项
  • DOI:
    10.1097/01.aoa.0000515760.42651.7a
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Krans;Gerald T. Cochran;D. Bogen
  • 通讯作者:
    D. Bogen
Analysis of the Uniform Accident and Sickness Policy Provision Law: Lessons for Social Work Practice, Policy, and Research
统一事故和疾病政策规定法分析:社会工作实践、政策和研究的经验教训
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran
Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective.
防滥用阿片类药物制剂和阿片类药物危机:药剂师的视角。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Shannon Gadd;Nicholas Cox;J. Samuelson;Amy Kenney;Kyle M. Turner;Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran
Latent classes and transitions for brief alcohol interventions in trauma settings : clinical and policy implications
创伤环境中短暂酒精干预的潜在类别和转变:临床和政策影响
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran

Gerald T. Cochran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gerald T. Cochran', 18)}}的其他基金

Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)
阿片类药物与酒精预防研究 (COAPS) 的共同使用
  • 批准号:
    10629264
  • 财政年份:
    2022
  • 资助金额:
    $ 147.87万
  • 项目类别:
Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Pro-gram Opioid Risk Assessment Tool
基于社区药房的处方药监测计划阿片类药物风险评估工具的调整和实施
  • 批准号:
    10621513
  • 财政年份:
    2022
  • 资助金额:
    $ 147.87万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10204570
  • 财政年份:
    2021
  • 资助金额:
    $ 147.87万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10551886
  • 财政年份:
    2021
  • 资助金额:
    $ 147.87万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10371130
  • 财政年份:
    2021
  • 资助金额:
    $ 147.87万
  • 项目类别:
Greater Intermountain Node
大山间节点
  • 批准号:
    10583147
  • 财政年份:
    2019
  • 资助金额:
    $ 147.87万
  • 项目类别:
Greater Intermountain Node
大山间节点
  • 批准号:
    10581531
  • 财政年份:
    2019
  • 资助金额:
    $ 147.87万
  • 项目类别:
Optimizing Pregnancy and Treatment Interventions for Moms 2.0
优化妈妈怀孕和治疗干预 2.0
  • 批准号:
    9789115
  • 财政年份:
    2018
  • 资助金额:
    $ 147.87万
  • 项目类别:
Prescription opioid misuse: Pharmacist-delivered intervention at point of service
处方阿片类药物滥用:药剂师在服务点提供干预
  • 批准号:
    9297643
  • 财政年份:
    2017
  • 资助金额:
    $ 147.87万
  • 项目类别:
The Influence of Formulary Management Strategies on Opioid Medication Use.
处方管理策略对阿片类药物使用的影响。
  • 批准号:
    8821933
  • 财政年份:
    2014
  • 资助金额:
    $ 147.87万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 147.87万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 147.87万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 147.87万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了